What is Bionex?
Bionex Pharmaceuticals LLC is a pharmaceutical development company focused on the formulation, development, and commercialization of advanced drug delivery systems. Their expertise spans topical, transdermal, and implant technologies. Beyond proprietary development, Bionex offers extensive Contract Research and Manufacturing Organization (CRMO) services, encompassing drug formulation development, product performance testing, and clinical supply manufacturing. The company actively pursues co-development partnerships and engages in research and development projects supported by entities such as the NIH and NSF, providing regulatory support and lifecycle management for pharmaceutical products.
How much funding has Bionex raised?
Bionex has raised a total of $41K across 1 funding round:
Debt
$41K
Debt (2021): $41K with participation from PPP
What's next for Bionex?
With the recent influx of substantial expansion capital, Bionex Pharmaceuticals LLC is poised for accelerated growth and enhanced service offerings. The company's strategic positioning in developing innovative drug delivery systems, coupled with its robust CRMO capabilities, suggests a trajectory focused on scaling operations and expanding its market reach. Future endeavors will likely involve strengthening R&D initiatives, forging new co-development partnerships, and potentially leveraging this investment to broaden its service portfolio and solidify its presence in the competitive pharmaceutical landscape.
See full Bionex company page
